Actively Recruiting
ioMRI in the Surgery of Brain Metastases.
Led by Technical University of Munich · Updated on 2026-05-05
154
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to improve the surgical treatment of brain metastases through the use of advanced imaging techniques. The investigators are examining how intraoperative MRI (iMRI) can aid surgeons in precisely locating and removing tumors, with the potential to enhance surgical outcomes and reduce the need for additional procedures. While iMRI offers the promise of better tumor visualization during surgery, it is also associated with longer surgical times and may carry the risk of increased complications. This study seeks to carefully evaluate these aspects to determine the overall benefits and challenges of iMRI in brain metastasis surgeries. The ultimate aim is to enhance treatment effectiveness and improve recovery and health outcomes for participants dealing with brain metastases.
CONDITIONS
Official Title
ioMRI in the Surgery of Brain Metastases.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients for whom surgical resection of brain metastasis is indicated
You will not qualify if you...
- Age under 18 years
- Contraindications to 3 Tesla MRI
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Neurosurgery, München University Hospital rechts der Isar (MRI)
Munich, Germany, 81675
Actively Recruiting
Research Team
M
Maria Goldberg
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here